




Shock después de inyecciones subcutáneas de
polimetilmetacrilato
A 35-year-old transsexual (male to female) went to emer-
gency with 24 h of mild fever, cough and dyspnoea. Four
days before he had been submitted to multiple gluteus
subcutaneous injections of polymethylmethacrylate (PMMA)
microspheres. Patient had a past medical history of uncon-
trolled hypertension.
On admission patient had Glasgow Coma Scale Score of
15, tachypnea and tachycardia, with central cyanosis and
was sweating. No fever. Blood pressure was 100/70mmHg
and respiratory rate 40/min. Arterial blood gas analysis
under 15 l/min oxygen therapy by a non-rebreathing mask
with reservoir showed global respiratory insufficiency and
sever acidemia (pH 7.22, pO2 31mmHg, pCO2 49mmHg,
HCO3− 17.6mEq/L, SatO2 55%, lactate 6.17mmol/L). Heart
auscultation revealed audible S1 and S2 and chest aus-
cultation revealed bilateral rales. The remaining physical
examination just was unremarkable with exception of mild
redness, warmth and swelling of the gluteus. No fluctua-
tion was detected and no indication for surgical approach
was considered. Chest X-ray showed bilateral lung infiltra-
tes (Fig. 1A). At this time was intubated and mechanically
ventilated.
On intensive care unit (ICU) admission presented with
hypotension, tachycardia, oligoanuric renal failure, mixed
acidemia and pO2/FiO2 ratio of 40. Biochemistry showed:
normocytic normochromic anaemia, high white blood cells
count, coagulation times prolonged, acute renal lesion with
hyperkalemia, hyperbilirubinemia 1.49mg/dL [0.3--1.2],
conjugated bilirubin 0.79 [0--0.2], hepatic cytolysis high
lactate dehydrogenase and C-reactive protein. Patient was
started on empirical antibiotic therapy with meropenem due
to the inflammatory signs in gluteus.
Electrocardiogram showed sinus tachycardia with S1Q3T3
pattern. Computed tomography angiography ruled out pul-
monary embolism and disclosed bilateral consolidations
with air-bronchograms and ground-glass-appearing opacities
suggestive of alveolar damage (Fig. 1B--E). Transthoracic
echocardiogram revealed normal left ventricular systolic
function with no contractility alterations, valve dysfunctions
or pericardial effusion.
Pulse contour cardiac output (PiCCO) catheter was pla-
ced and haemodynamic monitoring showed low cardiac
index (CI), low intrathoracic blood volume index (ITBVI),
low central venous oxygen saturation (cvSatO2), high
venous-to-arterial CO2 gap (pCO2 gap), high extravascu-
lar lung water index (EVLWI) and normal systemic vascular
resistance (SVR) on norepinephrine 0.55g/kg/min. Distri-
butive shock (DS) with vasoplegia, functional hypovolemia
and pulmonary oedema complicated with multiple organ
dysfunction syndrome (MODS) was diagnosed (Table 1).
Patient was started on vasopressors and continuous renal
replacement technique. He developed severe (pO2/FiO2
ratio≤ 100)1 acute respiratory distress syndrome (ARDS)
with need of prone position and curarization.
Figure 1 1A. Chest X-ray showing bilateral lung infiltrates.
1B-E. Chest CT angiographyshowing bilateral consolidations
with air-bronchograms and ground-glass-appearing opacities
suggestive of alveolar damage.
Serologies for HIV, HBV, HCV, EBV, CMV, Mycoplasma
pneumoniae and respiratory virus were negative. Tra-
cheobronchial aspirate, uroculture and pneumococcal and
Legionella urinary antigen tests were negative. Three sets
of blood culture specimens exhibited no growth. Meropenem
stopped on the 5th day of therapy.
Patient remained apyretic, inflammatory markers
decreased and gluteus inflammatory signs improved rapidly.
Patient remained under continuous renal replacement
technique for 5 days with gradual recovery of renal function
and vasopressor support was stopped on 2nd day. He was
mechanically ventilated for 15 days and was extubated on
16th day.
Chest CT with significant reduction of pulmonary infiltra-
tes. Laboratory tests evidenced recovery of hepatic function
with correction of the coagulation disorder.
Patient was transferred to intermediate care on 17th day
and then to the general ward, requiring only physical reha-
bilitation.
Shock is a high mortality acute syndrome character-
ized by cellular dysoxia, and can lead if not quickly and
appropriately managed to organ failure and death. It is
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Table 1 PiCCO haemodynamic monitoring.
On admission After 12 h After 24 h After 36 h After 48 h After 72 h After 96 h
Norepinephrine, g/kg/min 0.55 0.18 0.05 0 0 0 0
BP, mmHg 151/66 139/66 145/80 148/89 90/54 179/103 121/70
HR, bpm 101 100 78 63 62 54 79
CVP, cm H2O 13 16 14 16 12 13 10
CI (2.8--3.4) 2.31 3.19 2.89 2.83 2.94 2.33 3.5
SVR (770--1500) 1169 731 1034 1115 630 1720 725
EVLWI (3--7) 21 16.7 12.4 11.3 9.8 8.2 12.4
ITBVI (850--1000) 486 594 619 676 714 766 1043
paO2, mmHg 61.5 95.3 122 116 70 162.6 111
aSatO2% 76 94.1 96.6 96 88 99.3 98
pvO2, mmHg 29.9 54.8 52 40 41 32.9 43
cvSatO2% 54 79.9 79.4 67 62 61.1 72
pCO2 gap 19 14.9 13.3 8 5 7 5.2
FiO2 (21--100%) 100 100 80 65 50 70 75
PEEP, cm H2O 16 16 16 16 14 10 12
Lactate, mmol/L 8.8 6.7 2.35 2.11 1.67 2.69 1.5
Hb, g/dL 10.9 10.8 9.6 8.6 7.7 8.5 8.3
BP, blood pressure; HR, heart rate; CVP, central venous pressure; CI, cardiac index; SVR, systemic vascular resistance; EVLWI, extravascular
lung water index; ITBVI, intrathoracic blood volume index; paO2, arterial oxygen partial pressure; aSatO2, arterial oxygen saturation;
pvO2, venous oxygen partial pressure; cvSatO2, central venous oxygen saturation; pCO2 gap, venous-to-arterial CO2 gap; FiO2, fraction
of inspired oxygen; PEEP, positive end-expiratory pressure; Hb, haemoglobin.
classically rated has hypovolemic, cardiogenic, obstructive
or distributive. The first three are associated with low
CI while distributive shock is associated with normal or
supranormal levels of CI,1 impaired distribution of microvas-
cular blood flow and metabolic distress. DS occurs mainly
during systemic inflammatory response syndrome (SIRS)
which can be due to infectious or non-infectious causes.
The most common aetiology of DS is septic shock. Non-
infectious causes include burns, pancreatitis, toxic shock
syndrome, anaphylaxis and drugs or toxins. PMMA is a
no biodegradable injectable filling used for a variety of
conditions such as percutaneous vertebroplasty and cosme-
tic soft tissue filling. PMMA subcutaneous injections local
complications are nodules, filler migration and granulomas.
Mostly described following percutaneous vertebroplasty
systemic complications include pulmonary embolism,2 pul-
monary embolism with ARDS,3 ventricular perforation,4
intracardiac embolism,5 aortic embolism,6 renal embolism7
and deep vein thrombosis.8
Our patient never had fever. Inflammatory markers
decreased rapidly and did not relapse after meropenem
has been stopped. No pathogenic organisms were isolated.
We assisted to a favourable evolution even in absence of
antibiotherapy. These facts make infectious aetiology less
probable. Most probable hypothesis due to patient’s history
of PMMA gluteus subcutaneous injections four days before,
absence of positive culture results and favourable evolution
just with organ support therapy is SIRS triggered by chemi-
cal insult induced by PMMA. To the best of our knowledge,
this is the first case reported in literature of shock and MODS
secondary to subcutaneous injection of PMMA.
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